Literature DB >> 12041516

Clinicopathologic features, diagnosis, and treatment of fibrosarcoma of bone.

Panayiotis J Papagelopoulos1, Evanthia C Galanis, Pantelis Trantafyllidis, Peter J Boscainos, Franklin H Sim, K Krishnan Unni.   

Abstract

Fibrosarcoma of bone is a relatively rare tumor; it accounts for less than 5% of bone sarcomas. The anatomical sites most commonly involved are the metaphyses of long tubular bones. Local pain, swelling, limitation of motion, and pathologic fracture are the common clinical signs and symptoms. Typical imaging findings include eccentrically located lytic lesions, with a geographic, moth-eaten, or permeative pattern of bone destruction, and extension into adjacent soft tissues. Surgery is the treatment of choice. The type of surgical procedure depends mainly on histologic grade, local conditions, and tumor location. With a high probability of metastases (>70%) after surgical treatment, perioperative adjuvant treatment modalities should be considered for high-grade tumors. The most important prognostic factors affecting survival include tumor grade, patient's age, and tumor location.

Entities:  

Mesh:

Year:  2002        PMID: 12041516

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  5 in total

1.  In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on human fibrosarcoma cells HT-1080.

Authors:  M Waheed Roomi; Vadim Ivanov; Tatiana Kalinovsky; Aleksandra Niedzwiecki; Matthias Rath
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  Chest wall tumors: Diagnosis, treatment and reconstruction.

Authors:  Guo-Qiang Lin; Ying-Qiu Li; Ling-Jin Huang; Fan-Yan Luo; Hai-He Jiang; Wan-Jun Luo
Journal:  Exp Ther Med       Date:  2015-03-13       Impact factor: 2.447

3.  Catalyser-21(TM), a mineral water derived from leaf soil, inhibits tumor cell invasion and angiogenesis.

Authors:  Jun Ye; Yuping Li; Takeki Hamasaki; Noboru Nakamichi; Takeshi Kawahara; Kazuhiro Osada; Kiichiro Teruya; Yuko Kato; Kazuko Toh; Masumi Abe; Yoshinori Katakura; Katsumi Noguchi; Sanetaka Shirahata
Journal:  Cytotechnology       Date:  2007-07-20       Impact factor: 2.058

4.  Malignant bone tumors (other than Ewing's): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS).

Authors:  Andrés Redondo; Silvia Bagué; Daniel Bernabeu; Eduardo Ortiz-Cruz; Claudia Valverde; Rosa Alvarez; Javier Martinez-Trufero; Jose A Lopez-Martin; Raquel Correa; Josefina Cruz; Antonio Lopez-Pousa; Aurelio Santos; Xavier García Del Muro; Javier Martin-Broto
Journal:  Cancer Chemother Pharmacol       Date:  2017-10-16       Impact factor: 3.333

5.  Primary bone tumors of adulthood.

Authors:  Harvey E L Teo; Wilfrid C G Peh
Journal:  Cancer Imaging       Date:  2004-03-29       Impact factor: 3.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.